Conclusion: According to our preliminary results, patient-derived xenografts

and tissue cultures maintain viability and appropriate responses to androgen.

Furthermore, PDX models may be useful for testing the individual responses

of prostate cancer patients to therapeutics, which would allow developing a

tool for personalized medicine to be used in prostate cancer research.